Similar articles

• Capreomycin compared with streptomycin in original treatment of pulmonary tuberculosis. XVI. A report of the Veterans Administration-Armed Forces Cooperative. Study on the Chemotherapy of Tuberculosis.

  Schwartz W. Schwartz W. Am Rev Respir Dis. 1966 Dec;94(6):858-64. doi: 10.1164/arrd.1966.94.6.858. Am Rev Respir Dis. 1966. PMID: 4958888 Clinical Trial. No abstract available.
• Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.

  Tousek J, Votruba R. Tousek J, et al. Chemotherapy. 1974;20(3):183-200. doi: 10.1159/000221808. Chemotherapy. 1974. PMID: 4605071 Clinical Trial. No abstract available.
• [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].

  Yamamoto M, Nakamura H. Yamamoto M, et al. Kekkaku. 1971 Jun;46(6):191-5. Kekkaku. 1971. PMID: 4997826 Japanese. No abstract available.
• Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.

  [No authors listed] [No authors listed] Br Med J. 1973 Apr 7;2(5857):7-11. Br Med J. 1973. PMID: 4633061 Free PMC article. Clinical Trial.
• Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials.

  Doster B, Murray FJ, Newman R, Woolpert SF. Doster B, et al. Am Rev Respir Dis. 1973 Feb;107(2):177-90. doi: 10.1164/arrd.1973.107.2.177. Am Rev Respir Dis. 1973. PMID: 4567069 Clinical Trial. No abstract available.